A new brain-computer interface (BCI) allows people with vocal tract and bodily paralysis to convey both speech and upper-body gestures simultaneously. The BCI successfully translated the thoughts of patients into commands that dictated the expressions of a full-body virtual avatar.
Scientists at Salk Institute create first microprotein atlas of human frontal cortex with and without Alzheimer's disease, identifying 1,067 new microproteins and a potential link to immune cell dysfunction in Alzheimer's. The atlas provides a system for investigating microproteins in aging and neurodegeneration, bringing scientists cl...
Researchers found that exosomes from people with shingles pain caused nerve cells to remain inflamed and transmit pain signals even after the virus clears the body. This discovery opens the door to new approaches for predicting, preventing, and treating post-herpetic neuralgia.
Researchers found that m6A, a small chemical modification on RNA, acts as a molecular delivery tag to transport specific RNAs to distant regions of neurons. The study provides a basis for investigating RNA delivery errors in brain disorders and may inform the development of new therapeutic strategies.
A new study found that a rare mutation in the fibronectin gene limits the accumulation of fibronectin in the blood-brain barrier, protecting against Alzheimer's disease. High levels of fibronectin were associated with vascular damage, inflammation, and disrupted communication between astrocytes and blood vessel cells.
Researchers have discovered a rare population of neurons in the cortex that can synchronize activity across large areas of the brain and promote sleep. These Sst-Chodl neurons were found to be active during the transition to sleep and could even help drive the process, suggesting that the cortex is not simply passive during sleep.
Researchers found three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease, suggesting a potential treatment. The extracts, including Uncaria rhynchophylla, Gardenia jasminoides, and Scutellaria baicalensis, improved cell viability and mitochondrial function in cells with reduced VPS13C expression.
A new study estimates that Parkinson's disease could cause a cumulative macroeconomic loss of CNY 473 billion between 2020 and 2040. The disease affects China's economy by reducing labor force participation, productivity, and investment in education and infrastructure.
Researchers from Fudan University developed a strategy to achieve efficient engraftment of macrophages in peripheral organs using Mr BMT, a technique that replaces microglia in the CNS. The study shows that Mr BMT preserves tissue homeostasis and innate immune response, with durable macrophage replacement lasting at least 9 months.
New research from Texas A&M University suggests that younger brains may be more vulnerable to post-traumatic epilepsy after traumatic brain injury, despite their flexibility to adapt. Older brains showed fewer signs of epilepsy but were vulnerable to neuroinflammation, circuit remodeling, and memory loss.
Researchers identified biomarkers of bone formation that declined with corticosteroid treatment, but recovered after transitioning to vamorolone. The study provides insights into the effects of corticosteroids on childhood growth and bone health.
Researchers discovered that psilocybin prevents nerve injury and associated symptoms in preclinical models, protecting sensory nerve endings and preserving touch sensation. Psilocybin may offer a new intervention for preventing chemotherapy-induced peripheral neuropathy, improving patients' quality of life.
Two UCLA studies published in Cell and Science uncover the role of metabolism and physical signals in guiding radial glia to produce specific cell types in the developing human cortex. Metabolic research found that the pentose phosphate pathway influences cell fate, while thalamic projections make direct physical contact with radial gl...
A. Campbell Sullivan, a neuropsychologist, discovered a gap between treatment and science of ALS and dementia in her own family. She notes that advances in genetics and biomarker discovery are transforming research and care in ALS and FTD.
A Boston University study analyzed 33 NFL players with confirmed CTE, revealing cognitive impairments in memory, executive function, language, and attention. The findings provide an important roadmap for recognizing CTE in living patients and highlight limitations of the NFL Concussion Settlement's testing program.
Researchers have discovered a critical signalling pathway that controls the timing of brain development, shedding new light on how neurodevelopmental disorders may develop. The study reveals the genetic processes that shape brain development and what happens when they become disrupted.
Adrian Bird and Huda Zoghbi's groundbreaking work on epigenetics in neurological diseases has reshaped scientists' understanding of brain disease. Their discoveries have inspired international efforts to develop genetic therapies for devastating conditions like Rett syndrome.
Researchers at Barrow Neurological Institute discovered a link between wildfire smoke and neurodegenerative diseases like Parkinson's and Alzheimer's. Wildfire smoke particles activate astrocytes, leading to inflammation and damage to nearby brain cells.
A Rutgers-led international team identified 36 genes linked to obsessive-compulsive disorder (OCD) and chronic tic disorders, providing a detailed biological understanding of how these conditions develop. The findings suggest that many of the genes are shared between the conditions and can be targeted using whole-network approaches.
A new study from the University of California San Diego reveals that the brain tracks subtle variations in breathing to decode neural activity patterns. Researchers found a precise connection between breathing patterns and brain activity, offering new avenues for understanding disorders like SUDEP and SIDS.
Researchers identified a compound, PF-04457845, that slows ALS progression in mice, with potential as a therapeutic option. The compound targets N-acyl taurines, which correlate with ALS progression, and has been proven safe in humans.
University Hospitals has received American Heart Association Get With The Guidelines - Stroke awards for its commitment to ensuring timely, appropriate treatment for stroke patients. The hospital has achieved high levels of quality care, including door-to-needle times of 45 minutes or less for 75% of patients.
A new guideline from the American Stroke Association emphasizes the importance of early, individualized rehabilitation to help survivors of stroke regain independence and quality of life. The comprehensive approach addresses physical, cognitive, communication, and emotional challenges throughout recovery.
Research identifies aberrant ERBB4 expression in excitatory neurons as an early driver of Alzheimer's disease pathologies, including neuronal hyperactivity, synapse loss, and cognitive decline. Manipulating ERBB4 expression in mouse models reveals its role in driving disease features, including reactive gliosis and amyloid buildup.
A study finds that dementia with Lewy bodies preferentially affects certain brain regions, including those with genes linked to mitochondrial function and synapses. These regions show distinctive patterns of serotonin, dopamine, and GABA receptors, suggesting a potential target for new treatments.
A new study published in The BMJ found that nearly a quarter of former NFL players who died from 2016 to 2021 had confirmed CTE, with stage IV CTE linked to symptoms typical of dementia. The study provides one of the most informative estimates to date of CTE burden among former NFL players.
A new T32 training program connects bioengineers and neurosurgeons to work on research projects improving neurosurgical practice. The program brings together postdoctoral associates and residents to collaborate on team-based research projects, closing the gap between neurosurgery and bioengineering.
A new research tool, PGS-TRI, analyzes family data to understand how genetics and environment contribute to autism risk. The tool provides a more precise look at how 'nature' and 'nurture' interact within families, allowing researchers to better understand the complex factors that shape a child's health.
A new University of Pittsburgh study found that low-frequency deep brain stimulation improves control of facial and tongue muscles involved in speaking and swallowing after traumatic brain injury. The treatment showed small but significant improvements in word intelligibility for one participant with TBI.
Salk Institute researchers found microglia's novel way to contribute to ALS progression and death, using TAM receptors to find and kill motor neurons in spinal cords of mice with ALS. The study suggests a new target for therapy innovation, but notes the complexity of variables involved.
Dr. Danesh, a professor at FAU's College of Education, has made exemplary contributions to audiology through research, education, and mentorship. His work has advanced the profession and demonstrated a sustained commitment to advancing audiology.
A study confirms the 20-item prosopagnosia index questionnaire is an effective screening tool for detecting developmental prosopagnosia, a condition where individuals struggle to recognize familiar faces. The researchers also identified opportunities for refinement to improve the questionnaire's accuracy.
Researchers discovered how anesthesia, surgery, and intensive care stress alter gene activity in the brain, leading to cognitive impairment and delirium. A new drug, vorinostat, reversed these changes, restoring memory formation and regulating the internal biological clock.
Researchers from Hebei Medical University review current evidence on prolonged disorders of consciousness (pDOC) management. They propose a brain communication network model to explain how brain injury leads to long-term unconsciousness, identifying key brain electrical signaling activity measures for diagnosis and treatment.
Researchers identified distinct patches of disorganized brain development in ASD brain organoids, suggesting a new model for autism pathogenesis. This study provides a new perspective on autism, highlighting the importance of understanding how brain cells assemble into tissues.
Researchers analyzed EBRAINS-hosted brain data to determine that whole-brain activity patterns predict stimulation outcomes better than local recordings. Targeting specific sensorimotor and visual networks reduces response variability by up to 24%. This study highlights the value of open datasets for enabling large-scale analyses.
A major European study published in PLOS One found that children from disadvantaged backgrounds are more likely to die from congenital anomalies, with the risk increasing after infancy. The research highlights the influence of social and economic factors on health outcomes, particularly in countries with lower GDP per capita.
The study found that epilepsy-associated disability-adjusted life years were concentrated in low- and lower-middle-income countries, with significant regional inequality. Progress has been made in China, including declining mortality rates, but challenges persist, particularly in rural areas where treatment gaps reach 60%–90%.
Researchers at UH College of Pharmacy are developing breakthroughs to combat sepsis, a leading cause of hospital deaths, and diseases such as Alzheimer's and sickle cell disease. A dual-action nanomedicine has shown a 100% survival rate in preclinical trials for sepsis treatment.
A new theory proposes that critical illness arises from loss of physiological coordination, not just organ failure. The Entropic Critical Illness Theory views living organisms as open systems with a continuous need to regulate entropy.
Researchers at Weill Cornell Medicine have identified structural changes that enable the LRRK2 protein to become overactive, a key step in Parkinson's disease progression. Understanding these changes is crucial for developing targeted therapies to slow or halt the disease.
The first complete marmoset genome is now available, providing a high-quality reference for studying complex diseases like Alzheimer's. The new genome reveals variation in genes linked to Alzheimer's disease, as well as immune system genes and previously un-catalogued ribosomal DNA genes.
The Barrow Neurological Institute is conducting a Phase 1/2 clinical trial investigating ibogaine as a therapeutic agent for treating traumatic brain injury (TBI). Researchers aim to enroll 40 participants and determine how effectively ibogaine addresses TBI symptoms and quality of life.
Researchers at Stanford University discovered that aging brings a large influx of immune cells into the brain, upending previous assumptions about the brain's immune system. The study suggests that these immune cells may interact with the brain and contribute to its resilience against Alzheimer's disease.
A new immunotherapy for Alzheimer's disease has shown promising results in a Phase 1 clinical trial. The treatment aims to reverse immune aging and reduce biomarkers of neuronal damage, supporting further clinical development of this innovative strategy.
The autism spectrum has become increasingly broad, leading to concerns about misdiagnosis and the loss of its meaning. Dame Uta Frith argues that a rethink is needed to examine whether the autism spectrum has become too broad, risking misunderstanding people's needs and misdirecting care.
University of Rhode Island researcher William Van Nostrand will study cerebral amyloid angiopathy (CAA) using a $1.5 million grant, aiming to elucidate disease mechanisms and identify early-stage biomarkers for this prevalent disease in the elderly population and Alzheimer's patients.
Researchers at UMass Chan Medical School have developed a microRNA-based gene therapy that suppresses mutant SOD1 production, delaying disease onset by 60 days and extending lifespan by 100 days in mice models of ALS. The therapy, delivered via adeno-associated virus (AAV) vector, preserves motor neurons and maintains neuromuscular con...
A new study published in the Journal of Inherited Metabolic Disease found that high-dose niacin therapy can improve survival outcomes in children with NAXD deficiency, a rare genetic disorder. The treatment has been shown to halt significant deterioration and reduce life-threatening complications.
Researchers have identified a panel of key proteins in blood that can predict the emergence of ALS symptoms months to years before they arise. This discovery could enable early intervention with preventative therapies.
A study found that brain immune cells undergo substantial remodeling in midlife, leading to chronic neuroinflammation and potential dementia risk. The research used advanced single-cell analysis techniques to analyze postmortem hippocampal tissue from 40 healthy adults.
Researchers developed a new methodology using artificial intelligence to analyze brain electrical activity during sleep, identifying early neural alterations and classifying patients into distinct biological subgroups. This non-invasive approach may facilitate earlier diagnosis of Alzheimer's disease.
Researchers identify a specialized lymphatic network in the brain that enables cerebrospinal fluid drainage, which declines with age but can be restored through intranasal VEGF-C delivery. This discovery provides new insights into brain waste clearance and its link to neurodegenerative disorders.
Researchers have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder, and other neurological conditions. The team developed compounds capable of inhibiting its activity, which may help advance therapeutic research for these disorders.
Researchers found that bee venom can improve motor function and cognitive decline in a mouse model of Parkinson's disease when used alongside conventional therapy. The study suggests promising benefits for developing adjunct therapies to improve treatment outcomes.
Researchers have developed a new assessment tool to standardize reporting of transcranial magnetic stimulation (TMS) studies. The Transcranial Magnetic Stimulation Reporting Assessment Tool (TMS-RAT) helps compare results, build on each other's findings, and support progress in brain stimulation research. This tool addresses the need f...
New evidence explains why certain parts of the brain are more vulnerable to neurodegenerative diseases. The study suggests that directing therapies to specific protein forms can lead to improved treatment outcomes. Researchers found that subtle differences in protein abundance and complexes assemble determine regional vulnerability.
A Chinese neurosurgical journal's study found that severe stenosis of major intracranial arteries increases the risk of cerebral infarction after revascularization surgery in moyamoya disease. Severe blockage was associated with postoperative infarctions, highlighting the importance of monitoring and mitigating this risk factor.
Researchers found that tau buildup in PSP affects brain networks involved in thinking, including the prefrontal cortex and anterior cingulate cortex. The study suggests that symptoms arise from both local tau-related damage and remote disruption of a broader cognitive network.
Researchers at Gunma University have identified a compact genetic switch that could revolutionize the treatment of drug-resistant epilepsy. The discovery, published in Molecular Therapy, offers new avenues for addressing this debilitating condition.